Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-076639
Filing Date
2024-03-25
Accepted
2024-03-25 17:25:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6318
2 GRAPHIC g602978g0322120126914.jpg GRAPHIC 2295
  Complete submission text file 0001193125-24-076639.txt   10709
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)